药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Ethyl biscoumacetate
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Ethyl biscoumacetate.
Flurandrenolide
(R)-warfarin
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with (R)-warfarin.
Flurandrenolide
Coumarin
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Coumarin.
Flurandrenolide
4-hydroxycoumarin
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with 4-hydroxycoumarin.
Flurandrenolide
Acenocoumarol
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Acenocoumarol.
Flurandrenolide
Phenprocoumon
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Phenprocoumon.
Flurandrenolide
Glycopyrronium
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Glycopyrronium.
Flurandrenolide
Mequitazine
Chlorprothixene may increase the arrhythmogenic activities of Mequitazine.
Flurandrenolide
Lithium hydroxide
Lithium hydroxide may increase the neurotoxic activities of Chlorprothixene.
Flurandrenolide
Lithium citrate
Lithium citrate may increase the neurotoxic activities of Chlorprothixene.
Flurandrenolide
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorprothixene.
Flurandrenolide
Benzylpenicilloyl polylysine
Chlorprothixene may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Flurandrenolide
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Chlorprothixene.
Flurandrenolide
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Dexmethylphenidate.
Flurandrenolide
Amisulpride
Chlorprothixene may increase the antipsychotic activities of Amisulpride.
Flurandrenolide
Umeclidinium
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Umeclidinium.
Flurandrenolide
Tiotropium
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Tiotropium.
Flurandrenolide
Secretin porcine
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Chlorprothixene.
Flurandrenolide
Pramlintide
The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Chlorprothixene.
Flurandrenolide
Mirabegron
The risk or severity of urinary retention can be increased when Chlorprothixene is combined with Mirabegron.